2,700
Participants
Start Date
February 10, 2021
Primary Completion Date
January 31, 2028
Study Completion Date
April 30, 2028
Rosuvastatin Calcium
Each participant will receive the usual treatment for their newly diagnosed blood clot in addition to the intervention they are randomized to.
Placebo Oral Tablet
Each participant will receive the usual treatment for their newly diagnosed blood clot in addition to the intervention they are randomized to.
RECRUITING
Foothills Medical Centre, Calgary
WITHDRAWN
Queen Elizabeth II Hospital, Halifax
RECRUITING
Hamilton General Hospital, Hamilton
RECRUITING
St. Joseph's Healthcare, Hamilton
RECRUITING
Juravinski Hospital, Hamilton
RECRUITING
The Ottawa Hospital, Ottawa
WITHDRAWN
Hôpital Montfort, Ottawa
RECRUITING
Niagara Health - St. Catharines Site, St. Catharines
NOT_YET_RECRUITING
Sunnybrook Hospital, Toronto
RECRUITING
University Health Network, Toronto
RECRUITING
Jewish General Hospital, Montreal
RECRUITING
McGill Univeristy Health Centre, Montreal
RECRUITING
CIUSSS de-l'Ouest-de-l'Ile-de-Montreal -St. Mary's Hospital Center, Montreal
RECRUITING
CHU de Quebec-Université Laval, Québec
NOT_YET_RECRUITING
Brest University Hospital Centre, Brest
NOT_YET_RECRUITING
Mater Misericordiae University Hospital, Dublin
NOT_YET_RECRUITING
University of Insubria, Varese
RECRUITING
Ostfold Hopsital, Sarpsborg
Lead Sponsor
Ottawa Hospital Research Institute
OTHER